Status:
COMPLETED
Effectiveness of a Novel Respirator With Chitosan Nanoparticles
Lead Sponsor:
University of Brasilia
Collaborating Sponsors:
University of Campinas, Brazil
Centro de Pesquisa em Biotecnologia Ltda
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
20-59 years
Phase:
NA
Brief Summary
The use of nanomaterials in semi-facial respirators could decrease the permeability of particles and promote a biocidal effect compared to conventional respirators (N95) and, therefore, to enhance the...
Detailed Description
Context for the latest register update (May, 2022): Our randomized controlled pilot trial was conducted from February until April 2021, following the same methodological procedures described within th...
Eligibility Criteria
Inclusion
- Full-time employees (defined as direct patient care for more than 24 hours weekly) and work primarily at the study site or co-participants (more than 75% of working hours).
- Professionals working in emergency departments, ICUs, and other hospital settings exposed to SARS-Cov-2.
- Negative clinical and laboratory results for SARS-Cov-2 infection (negative RT-PCR).
- Have previous experience using N95 PFF2 respirators.
Exclusion
- Pregnant or breastfeeding women.
- History of high-risk comorbidities, such as high-risk heart disease or respiratory diseases.
- Presence of heterogeneous facial anatomical characteristics such as bulky beard, facial deformities, or facial dimensions incompatible with the respirators.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04490200
Start Date
March 1 2021
End Date
June 28 2023
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HRAN (Hospital Regional da Asa Norte)
Brasília, Brazil